Competing endogenous RNA networks in cervical cancer: function, mechanism and perspective

References

• Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30.
   PubMed Web of Science ®Google Scholar
• Sanchez-Mejias A, Tay Y. Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics. J Hematol Oncol. 2015;8:30.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hou J, He D. The emerging function and mechanism of ceRNAs in cancer. Trends Genet. 2016;32:211–224.
   PubMed Web of Science ®Google Scholar
• Qu J, Li M, Zhong W, et al. Competing endogenous RNA in cancer: a new pattern of gene expression regulation. Int J Clin Exp Med. 2015;8:17110–17116.
   PubMed Web of Science ®Google Scholar
• Yang C, Wu D, Gao L, et al. Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives. Oncotarget 2016;7:13479–13490.
   PubMed Web of Science ®Google Scholar
• Qi X, Zhang DH, Wu N, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52:710–718.
   PubMed Web of Science ®Google Scholar
• Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods. 2007;4:721–726.
   PubMed Web of Science ®Google Scholar
• Seitz H. Redefining microRNA targets. Curr Biol. 2009;19:870–873.
   PubMed Web of Science ®Google Scholar
• Poliseno L, Salmena L, Zhang J, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010;465:1033–1038.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell 2011;146:353–358.
   PubMed Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–159.
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang X, Yang YM, et al. Increased expression of the long noncoding RNA CRNDE-h indicates a poor prognosis in colorectal cancer, and is positively correlated with IRX5 mRNA expression. Onco Targets Ther. 2016;9:1437–1448.
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun S, Pu JK, et al. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis. 2012;48:1–8.
   PubMed Web of Science ®Google Scholar
• Chang Q, Chen J, Beezhold KJ, et al. JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma. Mol Cancer. 2009;8:64.
   PubMed Web of Science ®Google Scholar
• Cifola I, Spinelli R, Beltrame L, et al. Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile. Mol Cancer. 2008;7:6
   PubMed Web of Science ®Google Scholar
• Meng Y, Li Q, Li L, et al. The long non-coding RNA CRNDE promotes cervical cancer cell growth and metastasis. Biol Chem. 2017;399:93–100.
   PubMed Web of Science ®Google Scholar
• Wang Q, Yang L, Hu X, et al. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo. Oncotarget 2017;8:3441–3453.
   PubMedGoogle Scholar
• Hua F, Liu S, Zhu L, et al. Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/beta-catenin signaling pathway in cervical cancer. Biomed Pharmacother. 2017;92:1128–1134.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang X, Klibanski A. MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol. 2012;48:R45–R53.
   PubMed Web of Science ®Google Scholar
• Benetatos L, Vartholomatos G, Hatzimichael E. MEG3 imprinted gene contribution in tumorigenesis. Int J Cancer. 2011;129:773–779.
   PubMed Web of Science ®Google Scholar
• Lu KH, Li W, Liu XH, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. Bmc Cancer. 2013;13:461.
   PubMed Web of Science ®Google Scholar
• Braconi C, Kogure T, Valeri N, et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011;30:4750–4756.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Z, Wang J, et al. LncRNA MEG3 has anti-activity effects of cervical cancer. Biomed Pharmacother. 2017;94:636–643.
   PubMed Web of Science ®Google Scholar
• Xin Y, Li Z, Shen J, et al. CCAT1: a pivotal oncogenic long non-coding RNA in human cancers. Cell Prolif. 2016;49:255–260.
   PubMed Web of Science ®Google Scholar
• Zhang J, Gao Y. CCAT-1 promotes proliferation and inhibits apoptosis of cervical cancer cells via the Wnt signaling pathway. Oncotarget 2017;8:68059–68070.
   PubMedGoogle Scholar
• Hung T, Wang Y, Lin MF, et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet. 2011;43:621–629.
   PubMed Web of Science ®Google Scholar
• Huang HW, Xie H, Ma X, et al. Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer. Eur Rev Med Pharmacol Sci. 2017;21:4529–4535.
   PubMed Web of Science ®Google Scholar
• Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell 1988;54:787–793.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Takahashi N, Kakegawa E, et al. The GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a result of t(1;3)(q25;q27) in a patient with B-cell lymphoma. Cancer Genet Cytogenet. 2008;182:144–149.
   PubMedGoogle Scholar
• Cao S, Liu W, Li F, et al. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer. Int J Clin Exp Pathol. 2014;7:6776–6783.
   PubMed Web of Science ®Google Scholar
• Corcoran DL, Pandit KV, Gordon B, et al. Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. Plos One. 2009;4:e5279.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhu J. Elevated expression levels of long non-coding RNA, Loc554202, are predictive of poor prognosis in cervical cancer. Tohoku J Exp Med. 2017;243:165–172.
   PubMed Web of Science ®Google Scholar
• Quagliata L, Matter MS, Piscuoglio S, et al. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology. 2014;59:911–923.
   PubMed Web of Science ®Google Scholar
• Luan X, Wang Y. Long non-coding RNA XLOC_006390 promotes cervical cancer proliferation and metastasis through the regulation of SET domain containing 8. Oncol Rep. 2017;38:159–166.
   PubMed Web of Science ®Google Scholar
• Sun NX, Ye C, Zhao Q, et al. Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer. Plos One. 2014;9:e100340
   PubMed Web of Science ®Google Scholar
• Hu YC, Wang AM, Lu JK, et al. Long noncoding RNA HOXD-AS1 regulates proliferation of cervical cancer cells by activating Ras/ERK signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21:5049–5055.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang W, Li T, et al. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis. Biomed Pharmacother. 2016;80:73–79.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang Y, Li L, et al. LncRNA SNHG1 enhances cell proliferation, migration, and invasion in cervical cancer. Biochem Cell Biol. 2018;96:38–43.
   PubMed Web of Science ®Google Scholar
• Liu C, Wu HT, Zhu N, et al. Steroid receptor RNA activator: biologic function and role in disease. Clin Chim Acta. 2016;459:137–146.
   PubMed Web of Science ®Google Scholar
• Yan R, Wang K, Peng R, et al. Genetic variants in lncRNA SRA and risk of breast cancer. Oncotarget 2016;7:22486–22496.
   PubMedGoogle Scholar
• Hussein-Fikret S, Fuller PJ. Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours. Mol Cell Endocrinol. 2005;229:149–160.
   PubMed Web of Science ®Google Scholar
• Eoh KJ, Paek J, Kim SW, et al. Long non-coding RNA, steroid receptor RNA activator (SRA), induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines. Oncol Rep 2017;38:3481–3488.
   PubMed Web of Science ®Google Scholar
• Cao W, Peng T, Zhou Y. Long noncoding RNA activated by transforming growth factor-beta promotes cancer development and is a prognostic marker in cervical cancer. J Can Res Ther. 2017;13:801–806.
   PubMed Web of Science ®Google Scholar
• Ji Q, Zhang L, Liu X, et al. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer. 2014;111:736–748.
   PubMed Web of Science ®Google Scholar
• Pang EJ, Yang R, Fu XB, et al. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumour Biol. 2015;36:2403–2407.
   PubMedGoogle Scholar
• Wang J, Su L, Chen X, et al. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. Biomed Pharmacother. 2014;68:557–564.
   PubMed Web of Science ®Google Scholar
• Yang L, Bai HS, Deng Y, et al. High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. Eur Rev Med Pharmacol Sci. 2015;19:3187–3193.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang L, Chen C, et al. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications. Mol Cancer. 2018;17:22
   PubMed Web of Science ®Google Scholar
• Svoronos AA, Engelman DM, Slack FJ. OncomiR or tumor suppressor? the duplicity of MicroRNAs in cancer. Cancer Res. 2016;76:3666–3670.
   PubMed Web of Science ®Google Scholar
• Shen J, Hung MC. Signaling-mediated regulation of MicroRNA processing. Cancer Res. 2015;75:783–791.
   PubMed Web of Science ®Google Scholar
• Granados-Lopez AJ, Ruiz-Carrillo JL, Servin-Gonzalez LS, et al. Use of mature miRNA strand selection in miRNAs families in cervical cancer development. IJMS. 2017;18:407.
   Google Scholar
• Servín-González L, Granados-López A, López J. Families of microRNAs expressed in clusters regulate cell signaling in cervical cancer. Ijms. 2015;16:12773–12790.
   Google Scholar
• Hu T, Chang Y-F, Xiao z, et al. miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD. Oncotarget 2016;7:86103–86116.
   PubMedGoogle Scholar
• Wang Y, Tian Y. miR-206 inhibits cell proliferation, migration, and invasion by targeting BAG3 in human cervical cancer. Oncol Res. 2018;26:923.
   PubMed Web of Science ®Google Scholar
• Ling S, Ruiqin M, Guohong Z, et al. Decreased microRNA-206 and its function in cervical cancer. Eur J Gynaecol Oncol. 2015;36:716–721.
   PubMed Web of Science ®Google Scholar
• Hao Z, Yang J, Wang C, et al. MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer. Int J Clin Exp Med 2015;8:480–487.
   PubMed Web of Science ®Google Scholar
• Liu S, Zhang P, Chen Z, et al. MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells. Febs Lett. 2013;587:2247–2253.
   PubMed Web of Science ®Google Scholar
• Park S, Eom K, Kim J, et al. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer. BMC Cancer. 2017;17:658
   PubMed Web of Science ®Google Scholar
• Azizmohammadi S, Safari A, Azizmohammadi S, et al. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection. QJM 2017;110:11–15.
   PubMed Web of Science ®Google Scholar
• Liu W, Gao G, Hu X, et al. Activation of miR-9 by human papillomavirus in cervical cancer. Oncotarget 2014;5:11620–11630.
   PubMedGoogle Scholar
• Zhang J, Jia J, Zhao L, et al. Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell. Mol Carcinog. 2016;55:732–742.
   PubMed Web of Science ®Google Scholar
• Long MJ, Wu FX, Li P, et al. MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells. Cancer Lett. 2012;324:186–196.
   PubMed Web of Science ®Google Scholar
• Zhai L, Li Y, Lan X, et al. MicroRNA-10a-5p suppresses cancer proliferation and division in human cervical cancer by targeting BDNF. Exp Ther Med. 2017;14:6147–6151.
   PubMed Web of Science ®Google Scholar
• Huang N, Wu J, Qiu W, et al. MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin. Cancer Biol Ther. 2015;16:941–948.
   PubMed Web of Science ®Google Scholar
• Wen F, Xu JZ, Wang XR. Increased expression of miR-15b is associated with clinicopathological features and poor prognosis in cervical carcinoma. Arch Gynecol Obstet. 2017;295:743–749.
   PubMed Web of Science ®Google Scholar
• DU X, Lin LI, Zhang L, et al. microRNA-195 inhibits the proliferation, migration and invasion of cervical cancer cells via the inhibition of CCND2 and MYB expression. Oncol Lett.2015;10:2639–2643.
   PubMed Web of Science ®Google Scholar
• Wang N, Wei H, Yin D, et al. MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a. Tumour Biol. 2016;37:4711–4720.
   PubMedGoogle Scholar
• Li Z, Wang H, Wang Z, et al. MiR-195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1. Tumor Biol. 2016;37:6457–6463.
   PubMedGoogle Scholar
• Zhou Q, Han LR, Zhou YX, et al. MiR-195 suppresses cervical cancer migration and invasion through targeting Smad3. Int J Gynecol Cancer.2016;26:817–824.
   PubMed Web of Science ®Google Scholar
• Song R, Cong L, Ni G, et al. MicroRNA-195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF. Oncol Lett. 2017;14:767–775.
   PubMed Web of Science ®Google Scholar
• Wei Q, Li YX, Liu M, et al. MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. Iubmb Life. 2012;64:697–704.
   PubMed Web of Science ®Google Scholar
• Liu S, Pan X, Yang Q, et al. MicroRNA-18a enhances the radiosensitivity of cervical cancer cells by promoting radiation-induced apoptosis. Oncol Rep. 2015;33:2853–2862.
   PubMed Web of Science ®Google Scholar
• Xu XM, Wang XB, Chen MM, et al. MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. Cancer Lett. 2012;322:148–158.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Zhong W, et al. Correlation between miR-19a inhibition and radiosensitivity in SiHa cervical cancer cells. J Buon. 2017;22:1505–1508.
   PubMed Web of Science ®Google Scholar
• Shen Y, Li Y, Ye F, et al. Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues. Exp Mol Med. 2011;43:358–366.
   PubMed Web of Science ®Google Scholar
• Au YC, Tsang TY, Yau PL, et al. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Oncogene 2011;30:2401–2410.
   PubMed Web of Science ®Google Scholar
• Campos-Viguri GE, Jimenez-Wences H, Peralta-Zaragoza O, et al. miR-23b as a potential tumor suppressor and its regulation by DNA methylation in cervical cancer. Infect Agents Cancer. 2015;10:42.
   PubMed Web of Science ®Google Scholar
• Yeung CL, Tsang TY, Yau PL, et al. Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3. Oncotarget 2017;8:12158–12173.
   PubMedGoogle Scholar
• Wang W, Li Y, Liu N, et al. MiR-23b controls ALDH1A1 expression in cervical cancer stem cells. Bmc Cancer. 2017;17:292
   PubMed Web of Science ®Google Scholar
• Song J, Li Y. miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells. Cancer Sci. 2017;108:23–31.
   PubMed Web of Science ®Google Scholar
• Kong Q, Tang Z, Xiang F, et al. Diagnostic value of serum hsa-mir-92a in patients with cervical cancer. Clin Lab. 2017;63:335–340.
   PubMed Web of Science ®Google Scholar
• Zhou C, Shen L, Mao L, et al. miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7. Biochem Biophys Res Commun. 2015;458:63–69.
   PubMed Web of Science ®Google Scholar
• Luo S, Li N, Yu S, et al. MicroRNA-92a promotes cell viability and invasion in cervical cancer via directly targeting Dickkopf-related protein 3. Exp Ther Med.2017;14:1227–1234.
   PubMed Web of Science ®Google Scholar
• Su Z, Yang H, Zhao M, et al. MicroRNA-92a promotes cell proliferation in cervical Cancer via inhibiting p21 expression and promoting cell cycle progression. Oncol Res. 2017;25:137–145.
   PubMed Web of Science ®Google Scholar
• Xiong XD, Luo XP, Cheng J, et al. A genetic variant in pre-miR-27a is associated with a reduced cervical cancer risk in southern Chinese women. Gynecol Oncol. 2014;132:450–454.
   PubMed Web of Science ®Google Scholar
• Sun Y, Yang X, Liu M, et al. B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells. Cancer Lett. 2016;375:284–292.
   PubMed Web of Science ®Google Scholar
• Yao J, Deng B, Zheng L, et al. miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition. Oncol Rep. 2016;35:1645–1651.
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu F, Mao X, et al. Elevation of miR-27b by HPV16 E7 inhibits PPARgamma expression and promotes proliferation and invasion in cervical carcinoma cells. Int J Oncol. 2015;47:1759–1766.
   PubMed Web of Science ®Google Scholar
• Liu F, Zhang S, Zhao Z, et al. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer. Oncotarget 2016;7:19666–19679.
   PubMedGoogle Scholar
• Li Y, Wang F, Xu J, et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol. 2011;224:484–495.
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Kinoshita T, Nohata N, et al. Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma. Int J Oncol. 2013;43:1855–1863.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang Z, Xiao Z, et al. Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer. Oncotarget 2017;8:14655–14665.
   PubMedGoogle Scholar
• Wang X, Wang HK, McCoy JP, et al. Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA. 2009;15:637–647.
   PubMed Web of Science ®Google Scholar
• Ribeiro J, Marinho-Dias J, Monteiro P, et al. miR-34a and miR-125b Expression in HPV infection and cervical cancer development. Biomed Res Int. 2015;2015:304584
   PubMedGoogle Scholar
• Yang SF, Liu YF, Cheng CW, et al. Impact of microRNA-34a and polymorphism of its target gene CA9 on susceptibility to uterine cervical cancer. Oncotarget 2017;8:77860–77871.
   PubMedGoogle Scholar
• Zhu Y, Han Y, Tian T, et al. MiR-21-5p, miR-34a, and human telomerase RNA component as surrogate markers for cervical cancer progression. Pathol Res Pract 2018;214:374–379.
   PubMed Web of Science ®Google Scholar
• Yuan F, Sun R, Chen P, et al. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk. Tumour Biol. 2016;37:6267–6273.
   PubMedGoogle Scholar
• Wang P, Zhai G, Bai Y. Values of miR-34a and miR-218 expression in the diagnosis of cervical cancer and the prediction of prognosis. Oncol Lett. 2018;15:3580–3585.
   PubMed Web of Science ®Google Scholar
• Li B, Hu Y, Ye F, et al. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Int J Gynecol Cancer. 2010;20:597–604.
   PubMed Web of Science ®Google Scholar
• Geng D, Song X, Ning F, et al. MiR-34a inhibits viability and invasion of human papillomavirus-positive cervical cancer cells by targeting E2F3 and regulating survivin. Int J Gynecol Cancer. 2015;25:707–713.
   PubMed Web of Science ®Google Scholar
• Wang JH, Zhang L, Ma YW, et al. microRNA-34a-upregulated retinoic acid-inducible gene-i promotes apoptosis and delays cell cycle transition in cervical cancer cells. Dna Cell Biol. 2016;35:267–279.
   PubMed Web of Science ®Google Scholar
• Pang RT, Leung CO, Ye TM, et al. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis. 2010;31:1037–1044.
   PubMed Web of Science ®Google Scholar
• Zhang R, Su J, Xue SL, et al. HPV E6/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer. Am J Cancer Res 2016;6:312–320.
   PubMed Web of Science ®Google Scholar
• Li J, Yu L, Shen Z, et al. miR-34a and its novel target, NLRC5, are associated with HPV16 persistence. Infect Genet Evol. 2016;44:293–299.
   PubMed Web of Science ®Google Scholar
• Chandrasekaran KS, Sathyanarayanan A, Karunagaran D. Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells. Tumor Biol. 2016;37:13155–13166.
   PubMedGoogle Scholar
• Wang X, Xie Y, Wang J. Overexpression of MicroRNA-34a-5p inhibits proliferation and promotes apoptosis of human cervical cancer cells by downregulation of Bcl-2. Oncol Res. 2017;26:977.
   PubMed Web of Science ®Google Scholar
• Lopez JA, Alvarez-Salas LM. Differential effects of miR-34c-3p and miR-34c-5p on SiHa cells proliferation apoptosis, migration and invasion. Biochem Biophys Res Commun. 2011;409:513–519.
   PubMed Web of Science ®Google Scholar
• Li BH, Zhou JS, Ye F, et al. Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein. Eur J Cancer. 2011;47:2166–2174.
   PubMed Web of Science ®Google Scholar
• Xin JX, Yue Z, Zhang S, et al. miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2. Oncol Lett. 2013;6:1025–1030.
   PubMed Web of Science ®Google Scholar
• Wang L, Chang L, Li Z, et al. miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway. Med Oncol. 2014;31:934.
   PubMed Web of Science ®Google Scholar
• Wilting SM, van Boerdonk RA, Henken FE, et al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer. 2010;9:167.
   PubMed Web of Science ®Google Scholar
• Wu H, Zhang J. miR-124 rs531564 polymorphism influences genetic susceptibility to cervical cancer. Int J Clin Exp Med 2014;7:5847–5851.
   PubMed Web of Science ®Google Scholar
• Zhang X, Cai D, Meng L, et al. MicroRNA-124 inhibits proliferation, invasion, migration and epithelial-mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1. Oncol Rep.2016;36:2321–2328.
   PubMed Web of Science ®Google Scholar
• Wang P, Zhang L, Zhang J, et al. MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1. Exp Ther Med. 2018;15:1385–1393.
   PubMed Web of Science ®Google Scholar
• Qin X, Wan Y, Wang S, et al. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2. Drug Des Devel Ther. 2016;10:71–79.
   PubMed Web of Science ®Google Scholar
• Fan Z, Cui H, Yu H, et al. MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression. Oncogenesis 2016;5:e197.
   PubMed Web of Science ®Google Scholar
• Martinez-Acuna N, Gonzalez-Torres A, Tapia-Vieyra JV, et al. MARK1 is a novel target for miR-125a-5p: implications for cell migration in cervical tumor cells. Mirna. 2017;7:54.
   Google Scholar
• Qin W, Dong P, Ma C, et al. MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways. Oncogene 2012;31:4067–4075.
   PubMed Web of Science ®Google Scholar
• Yue C, Wang M, Ding B, et al. Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population. Gynecol Oncol. 2011;122:33–37.
   PubMed Web of Science ®Google Scholar
• Xu H, Zhu J, Hu C, et al. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway. J Physiol Biochem. 2016;72:721–732.
   PubMed Web of Science ®Google Scholar
• Yang M, Zhai X, Ge T, et al. MiR-181a-5p promotes proliferation and invasion, and inhibits apoptosis of cervical cancer cells via regulating Inositol Polyphosphate-5-Phosphatase A (INPP5A). Oncol Res. 2017;26:703.
   PubMed Web of Science ®Google Scholar
• Chen Y, Ke G, Han D, et al. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD. Exp Cell Res. 2014;320:12–20.
   PubMed Web of Science ®Google Scholar
• Ke G, Liang L, Yang JM, et al. MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene. Oncogene 2013;32:3019–3027.
   PubMed Web of Science ®Google Scholar
• Luo C, Qiu J. miR-181a Inhibits cervical cancer development via downregulating GRP78. Oncol Res. 2017;25:1341–1348.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang YL, Liu S, et al. miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells. Febs Lett. 2014;588:124–130.
   PubMed Web of Science ®Google Scholar
• How C, Hui AB, Alajez NM, et al. MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer. Plos One. 2013;8:e67846
   PubMed Web of Science ®Google Scholar
• Wang L, Wang Q, Li HL, et al. Expression of MiR200a, miR93, metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma–relationship with prognosis. Asian Pac J Cancer Prev.2013;14:2113–2118.
   PubMedGoogle Scholar
• Zeng F, Xue M, Xiao T, et al. MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1. Biomed Pharmacother. 2016;79:294–301.
   PubMed Web of Science ®Google Scholar
• Cheng YX, Zhang QF, Hong L, et al. MicroRNA-200b suppresses cell invasion and metastasis by inhibiting the epithelial-mesenchymal transition in cervical carcinoma. Mol Med Rep.2016;13:3155–3160.
   PubMed Web of Science ®Google Scholar
• Cheng YX, Chen GT, Chen C, et al. MicroRNA-200b inhibits epithelial-mesenchymal transition and migration of cervical cancer cells by directly targeting RhoE. Mol Med Rep.2016;13:3139–3146.
   PubMed Web of Science ®Google Scholar
• Mei J, Wang DH, Wang LL, et al. MicroRNA-200c suppressed cervical cancer cell metastasis and growth via targeting MAP4K4. Eur Rev Med Pharmacol Sci. 2018;22:623–631.
   PubMed Web of Science ®Google Scholar
• Peng L, Yuan XQ, Li GC. The emerging landscape of circular RNA ciRS-7 in cancer (Review). Oncol Rep. 2015;33:2669–2674.
   PubMed Web of Science ®Google Scholar
• Xu L, Zhang M, Zheng X, et al. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2017;143:17–27.
   PubMed Web of Science ®Google Scholar
• Zhao ZJ, Shen J. Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol. 2017;14:514–521.
   PubMed Web of Science ®Google Scholar
• Ji F, Wuerkenbieke D, He Y, et al. Long noncoding RNA HOTAIR: an oncogene in human cervical cancer interacting with MicroRNA-17-5p. Oncol Res. 2017;9:353–361.
   Google Scholar
• Sun J, Chu H, Ji J, et al. Long non-coding RNA HOTAIR modulates HLA-G expression by absorbing miR-148a in human cervical cancer. Int J Oncol. 2016;49:943–952.
   PubMed Web of Science ®Google Scholar
• Li Q, Feng Y, Chao X, et al. HOTAIR contributes to cell proliferation and metastasis of cervical cancer via targetting miR-23b/MAPK1 axis. Biosci Rep. 2018;38:BSR20171563.
   PubMed Web of Science ®Google Scholar
• Liu S, Song L, Zeng S, et al. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells. Tumour Biol. 2016;37:633–640.
   PubMedGoogle Scholar
• Feng Y, Zou W, Hu C, et al. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin. Arch Biochem Biophys. 2017;623-624:20–30.
   PubMed Web of Science ®Google Scholar
• Shen CJ, Cheng YM, Wang CL. LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells. J Drug Target. 2017;25:637–644.
   PubMed Web of Science ®Google Scholar
• Zhu J, Shi H, Liu H, et al. Long non-coding RNA TUG1 promotes cervical cancer progression by regulating the miR-138-5p-SIRT1 axis. Oncotarget 2017;8:65253–65264.
   PubMedGoogle Scholar
• Zhu H, Zeng Y, Zhou CC, et al. SNHG16/miR-216-5p/ZEB1 signal pathway contributes to the tumorigenesis of cervical cancer cells. Arch Biochem Biophys. 2018;637:1–8.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhong X, Madison BB, et al. Assessing computational steps for CLIP-Seq data analysis. Biomed Res Int. 2015;2015:196082
   PubMedGoogle Scholar
• Zheng LL, Zhou KR, Liu S, et al. dreamBase: DNA modification, RNA regulation and protein binding of expressed pseudogenes in human health and disease. Nucleic Acids Res.2018;46:D85–D91.
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92–D97.
   PubMed Web of Science ®Google Scholar
• Denzler R, Agarwal V, Stefano J, et al. Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol Cell. 2014;54:766–776.
   PubMed Web of Science ®Google Scholar